Substituts à l'hémoglobine, érythropoïétine et fer : quel avenir en réanimation ?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Réanimation

• Publication date

  2003-12-01

• Fields of study

  Not labeled

• Identifiers
  DOI 10.1016/J.REAURG.2003.09.013
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• CORONARY ANGIOPIASTY irevention ot iscnemia auring percutaneous transluminal coronary angioplasty by transcatheter infusion of oxygenated Fluosol DA 20 %

  2005cited by this paper
• DCL-Hb for trauma patients with severe hemorrhagic shock: the European "On-Scene" Multicenter Study

  2003cited by this paper
• Perflubron emulsion (AF0144) augments harvesting of autologous blood: a phase II study in cardiac surgery.

  2002cited by this paper
• Use of Perflubron Emulsion to Decrease Allogeneic Blood Transfusion in High-blood-loss Non-Cardiac Surgery: Results of a European Phase 3 Study

  2002cited by this paper
• Efficacy of recombinant human erythropoietin in critically ill patients: a randomized controlled trial.

  2002cited by this paper
• Intravenous iron administration does not significantly increase the risk of bacteremia in chronic hemodialysis patients.

  2002cited by this paper
• Preserved Gastric Tonometric Variables in Cardiac Surgical Patients Administered Intravenous Perflubron Emulsion

  2002cited by this paper
• The successful use of hemoglobin-based oxygen carrier as a primary blood substitute during abdominal aneurysm repair with large blood loss.

  2001cited by this paper
• Efficacy of recombinant human erythropoietin in the critically ill patient: A randomized, double-blind, placebo-controlled trial*

  2001cited by this paper
• Anemia of the critically ill: "acute" anemia of chronic disease.

  2000cited by this paper
• Transfusions of polymerized bovine hemoglobin in a patient with severe autoimmune hemolytic anemia.

  2000cited by this paper
• Randomized Trial of Diaspirin Cross-linked Hemoglobin Solution as an Alternative to Blood Transfusion after Cardiac Surgery

  2000influential reference
• Randomized Safety Studies of Intravenous Perflubron Emulsion. II. Effects on Immune Function in Healthy Volunteers

  2000cited by this paper
• Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients

  2000influential reference
• Compatibility of Different Colloid Plasma Expanders with Perflubron Emulsion: An Intravital Microscopic Study in the Hamster

  2000influential reference
• Diaspirin Cross-Linked Hemoglobin (DCLHb) in the Treatment of Severe Traumatic Hemorrhagic Shock: A Randomized Controlled Efficacy Trial

  1999cited by this paper
• A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group.

  1999cited by this paper
• Iron and infection.

  1999cited by this paper
• Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients*

  1999cited by this paper
• Perflubron emulsion delays blood transfusions in orthopedic surgery. European Perflubron Emulsion Study Group.

  1999cited by this paper
• How and when to use erythropoietin

  1998influential reference
• The Effects of Increased Doses of Bovine Hemoglobin on Hemodynamics and Oxygen Transport in Patients Undergoing Preoperative Hemodilution for Elective Abdominal Aortic Surgery

  1998influential reference
• High-dose recombinant human erythropoietin stimulates reticulocyte production in patients with multiple organ dysfunction syndrome.

  1998influential reference
• The first randomized trial of human polymerized hemoglobin as a blood substitute in acute trauma and emergent surgery.

  1998cited by this paper
• Effect of hemoglobin- and Perflubron-based oxygen carriers on common clinical laboratory tests.

  1997cited by this paper
• Blood volume and cardiac index in rats after exchange transfusion with hemoglobin-based oxygen carriers.

  1997cited by this paper
• Initial evaluation of diaspirin cross-linked hemoglobin (DCLHb) as a vasopressor in critically ill patients.

  1997cited by this paper
• Use of recombinant human erythropoietin outside the setting of uremia.

  1997cited by this paper
• Recombinant Human Hemoglobin Does Not Affect Renal Function in Humans: Analysis of Safety and Pharmacokinetics

  1997cited by this paper
• Metoclopramide reduces the induction dose of propofol

  1997cited by this paper
• Resuscitation of pulmonary contusion: effects of a red cell substitute.

  1997cited by this paper
• Fluid resuscitation with O2 vs. non-O2 carriers after 2 h of hemorrhagic shock in conscious hamsters.

  1997cited by this paper
• Anemia of critical illness and erythropoietin deficiency

  1997cited by this paper
• Erythropoietin response is blunted in critically ill patients

  1997cited by this paper
• Clinical potential of intravenously administered perfluorocarbons.

  1997cited by this paper
• Recombinant human hemoglobin does not affect renal function in humans: analysis of safety and pharmacokinetics.

  1997cited by this paper
• A Pilot Study of the Effects of a Perflubron Emulsion, AF 0104, on Mixed Venous Oxygen Tension in Anesthetized Surgical Patients

  1996cited by this paper
• Effect of human hemoglobin on systemic and regional hemodynamics in a porcine model of endotoxemic shock.

  1996cited by this paper
• Physiology and pharmacokinetics of a novel hemoglobin-based oxygen carrier in humans.

  1996cited by this paper
• Effects of a novel hemoglobin-based oxygen carrier on percent oxygen saturation as determined with arterial blood gas analysis and pulse oximetry.

  1996cited by this paper
• A safety and efficacy comparison study of two dosing regimens of epoetin alfa in patients undergoing major orthopedic surgery.

  1996cited by this paper
• Role of endothelin in the cardiovascular effects of diaspirin crosslinked and stroma reduced hemoglobin.

  1996cited by this paper
• Phase I study of the safety and pharmacologic effects of diaspirin cross-linked hemoglobin solution.

  1996cited by this paper
• Limitations of the efficacy of hemoglobin-based oxygen-carrying solutions.

  1995cited by this paper
• Haemoglobin-based blood substitutes and infection.

  1995cited by this paper
• A double-blinded prospective evaluation of recombinant human erythropoietin in acutely burned patients.

  1995influential reference
• Diaspirin cross-linked hemoglobin resuscitation of hemorrhage: comparison of a blood substitute with hypertonic saline and isotonic saline.

  1995cited by this paper
• Haemoglobin-based blood substitutes and sepsis.

  1995cited by this paper
• Pharmacologic profile of diaspirin cross-linked hemoglobin in hemodialysis patients.

  1995cited by this paper
• Role of NO mechanism in cardiovascular effects of diaspirin cross-linked hemoglobin in anesthetized rats.

  1995cited by this paper
• Diaspirin Cross‐linked Hemoglobin Does Not Increase Brain Oxygen Consumption during Hypothermic Cardiopulmonary Bypass in Rabbits

  1995cited by this paper
• Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide.

  1994cited by this paper
• Hemoglobin stimulates mononuclear leukocytes to release interleukin-8 and tumor necrosis factor alpha.

  1994cited by this paper
• Effect of diaspirin cross-linked hemoglobin and norepinephrine on systemic hemodynamics and regional circulation in rats.

  1994cited by this paper
• Current status of injectable oxygen carriers.

  1994cited by this paper
• Erythropoietin response to critical illness.

  1993cited by this paper
• Cross-linked hemoglobin solution as a resuscitative fluid after hemorrhage in the rat.

  1991cited by this paper
• Hemodynamic effects and oxygen transport properties of a new blood substitute in a model of massive blood replacement.

  1990cited by this paper
• Fluosol DA-20 in the treatment of severe anemia: randomized, controlled study of 46 patients.

  1990cited by this paper
• Decreased erythropoietin response in patients with the anemia of cancer.

  1990cited by this paper
• Fluosol-DA as a red-cell substitute in acute anemia.

  1986cited by this paper
• The preoperative treatment of severely anemic patients with a perfluorochemical oxygen-transport fluid, Fluosol-DA.

  1982cited by this paper
• Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. V. The significance of the coordinated iron component.

  1979cited by this paper

• No citing papers are available for this paper.